Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001133416-25-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-11-07 | 2025-11-05 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.00 | -200 | 832.6K | -0.0% | -$1,200 |
| DT | 2025-11-07 | 2025-11-05 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +200 | 832.8K | +0.0% | +$478 |
| DT | 2025-11-07 | 2025-11-05 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | -200 | 24.2K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | S | D | 200 | $6.00 | 832,592 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-05 | M | A | 200 | $2.39 | 832,792 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-11-05 | M | D | 200 | $0.00 | 24,230 | D | $2.39 · 2018-12-14 to 2027-12-14 | 200 Common Stock | (F2) The options vested 100% on December 14, 2018. |